Stockreport

Enveric gains on out-licensing deal of new chemical entities for joint disease treatments [Seeking Alpha]

Enveric Biosciences, Inc.  (ENVB) 
PDF of cannabinoid-COX-2 conjugate compounds for both pharmaceutical and non-pharmaceutical applications for treatment of joint diseases, it said Tuesday. The term sheets [Read more]